10q10k10q10k.net
AVANOS MEDICAL, INC.

AVANOS MEDICAL, INC.AVNSEarnings & Financial Report

NYSE · health care

Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.

NextMar 31, 2026

AVNS Q3 2025 Key Financial Metrics

Revenue

$177.8M

Gross Profit

$86.0M

Operating Profit

$100.0K

Net Profit

$-1.4M

Gross Margin

48.4%

Operating Margin

0.1%

Net Margin

-0.8%

YoY Growth

4.3%

EPS

$-0.03

Financial Flow

AVANOS MEDICAL, INC. Q3 2025 Financial Summary

AVANOS MEDICAL, INC. reported revenue of $177.8M for Q3 2025, with a net profit of $-1.4M (-0.8% margin). Cost of goods sold was $91.8M, operating expenses totaled $85.9M.

Key Financial Metrics

Total Revenue$177.8M
Net Profit$-1.4M
Gross Margin48.4%
Operating Margin0.1%
Report PeriodQ3 2025

AVANOS MEDICAL, INC. Annual Revenue by Year

AVANOS MEDICAL, INC. annual revenue history includes year-by-year totals (for example, 2024 revenue was $687.8M).

YearAnnual Revenue
2024$687.8M
2023$673.3M
2022$820.0M

Income Statement

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Revenue$140.9M$166.1M$171.7M$170.4M$179.6M$167.5M$175.0M$177.8M
YoY Growth-35.2%-13.4%1.4%-0.5%27.5%0.8%1.9%4.3%

Balance Sheet

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Assets$1.69B$1.66B$1.66B$1.66B$1.15B$1.11B$1.04B$1.07B
Liabilities$456.1M$433.4M$435.8M$426.5M$325.7M$268.4M$262.7M$289.7M
Equity$1.24B$1.23B$1.22B$1.23B$828.5M$839.4M$776.3M$778.0M

Cash Flow

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Operating CF$12.7M$-8.0M$27.8M$23.0M$57.9M$25.7M$6.8M$14.0M